Netarsudil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Netarsudil ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Netarsudil is in a class of medications called rho kinase inhibitors.Netarsudil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Netarsudil Nitroso Impurity 1 CAS NO:23351-96-4 Chemically represented as 1-Nitroso-1H-benzo[d][1,2,3]triazole.Synchemia is the leading manufacturing and exporter of Netarsudil Nitroso Impurity 1.We supply Netarsudil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014258 |
| CAS No | NA |
| Mol.F. | C18H17N3O |
| Mol.Wt. | 291.4g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014259 |
| CAS No | NA |
| Mol.F. | C32H29F5N4O6 |
| Mol.Wt. | 660.59 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014260 |
| CAS No | NA |
| Mol.F. | C18H23N3O6 |
| Mol.Wt. | 377.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014261 |
| CAS No | 2901109-58-6 |
| Mol.F. | C17H19F6N3O4 |
| Mol.Wt. | 443.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014262 |
| CAS No | NA |
| Mol.F. | C19H23N3O5 |
| Mol.Wt. | 373.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014263 |
| CAS No | NA |
| Mol.F. | C7H9N3O5S |
| Mol.Wt. | 247.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014264 |
| CAS No | NA |
| Mol.F. | C22H29N7O2S |
| Mol.Wt. | 455.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N014265 |
| CAS No | NA |
| Mol.F. | C24H27N3O4 |
| Mol.Wt. | 421.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014266 |
| CAS No | NA |
| Mol.F. | C12H18N2O4 |
| Mol.Wt. | 254.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014267 |
| CAS No | NA |
| Mol.F. | C29H25ClFN5O5S |
| Mol.Wt. | 610.06 |
| INV STATUS | In Stock |
| CAT No | SRC-N014268 |
| CAS No | NA |
| Mol.F. | C25H29F3N4O5 |
| Mol.Wt. | 522.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014269 |
| CAS No | 3032026-54-0 |
| Mol.F. | C16H19N3O2 |
| Mol.Wt. | 285.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014270 |
| CAS No | NA |
| Mol.F. | C32H28F5N4O6 |
| Mol.Wt. | 659.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014271 |
| CAS No | NA |
| Mol.F. | C52H42F10N6O9 |
| Mol.Wt. | 1084.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014272 |
| CAS No | NA |
| Mol.F. | C13H16ClN3O4 |
| Mol.Wt. | 313.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N014273 |
| CAS No | NA |
| Mol.F. | C21H20N4O6 |
| Mol.Wt. | 424.4 g/mol |
| INV STATUS | In Stock |